Rimonabant, a selective cannabinoid 1 receptor antagonist, protects against light-induced retinal degeneration in vitro and in vivo

201719 citationsJournal Article

Authors

Good health and well-being

Published in: European Journal of Pharmacology

Volume 803, pp. 78-83

Field-Weighted Citation Impact: 0.57